BMS-986238, a second-generation macrocyclic peptide, is a potent PD-L1 inhibitor. BMS-986238 has the potential for the study of solid tumours and lymphomas (cancer of the lymphatic system)[1].
Molecular Weight:
2979.52
Purity:
99.94
CAS Number:
[2919596-13-5]
Formula:
C143H224N26O40S
Target:
PD-1/PD-L1
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
